Archived Intelligence
Researchers tested a combination of a cancer vaccine and a standard immune drug to treat lung cancer. The trial stopped early due to limited success, though one exceptional patient responded well. The findings suggest scientists still need better ways to predict who will benefit from these treatments.
Scientists have successfully edited the DNA of a marine worm called Urechis unicinctus for the first time. By using a tool called CRISPR, they turned off specific genes to see what happens to the worm's swimming abilities. This method could help us learn more about how marine animals develop and grow.
Scientists tested a new combination of a vaccine and an immune booster to fight a common type of lung cancer. While the treatment was safe, it only helped a small fraction of patients. The results suggest we still have a lot to learn about training our body's defences to attack tumours.
Scientists tested a new combination treatment for lung cancer, pairing a vaccine with standard immune boosters. While the treatment was safe, it only helped a small fraction of patients. By looking closely at why it fell short, researchers gathered valuable clues for building better treatments in the future.
Scientists have measured how the brain loses its flexibility as we grow up. By looking at brain scans of children, they found that staying flexible for longer might lead to better language skills. This helps explain why learning a new language gets harder as we get older.
Scientists have tracked how the brain's flexibility changes from infancy to the teenage years. They discovered that children with stronger language skills keep their brains in a flexible state for longer, which might explain why learning languages gets harder as we age.
Researchers measured brain plasticity in children from infancy to eighteen years old to understand why young kids learn languages so easily. They found that language-related brain regions harden at different rates, with a major plateau around age nine. Children whose brains remained flexible for longer tended to have better language skills.
A recent study explored how undergraduate students collaborate with artificial intelligence to solve complex calculus problems. Researchers discovered that students who actively engage and share their thought processes with the AI perform significantly better than those who simply ask for answers.
Just as a silent infection hides within the human body, vast amounts of human-made heat and carbon are stored in the deep waters of the Antarctic. Scientists warn that changes to this oceanic system could release trapped carbon, altering our climate in unpredictable ways.
When habitats change, animals and plants do not always disappear right away. Scientists reviewed over a hundred studies and found that this delay, known as extinction debt, often goes unnoticed in conservation plans. Understanding this hidden timeline might help us save vulnerable species before the bill comes due.
Researchers found that a recombinant influenza vaccine offers stronger short-term protection for adults with severe obesity compared to standard egg-based jabs. This modern approach to building immunity not only helps vulnerable groups fight the flu, but it also hints at a new era of genomic medicine.
Scientists have mapped a specific brain circuit in mice that links stress, brain plasticity, and mood. By tracing how the cortex talks to the hippocampus, researchers found a central pathway that might explain how rapid treatments actually work.
Scientists have mapped a specific pathway in the brain that connects stress, mood, and the ability of brain cells to adapt. By studying mice, researchers found that activating a three-part brain circuit relieves signs of low mood and helps brain cells form new connections.
For years, metabolic diseases have acted like silent invaders, damaging the heart and kidneys long before symptoms appear. A recent review suggests that GLP-1 receptor agonists, originally designed for diabetes, could offer a powerful defence against this interconnected web of cardiovascular and renal threats.
Scientists tested a new vaccine combined with standard treatment to fight lung cancer. While the overall results were limited, one patient's amazing recovery suggests that specific genetic markers might help doctors predict who will benefit most.
A recent clinical review highlights how GLP-1 receptor agonists treat multiple human conditions by targeting networks of receptors. This multi-target approach is paving the way for future genomic and precision medicine programmes to tackle complex systemic diseases.
Researchers tested a new combination of a cancer vaccine and a standard drug to boost the immune system against lung cancer. While the treatment was safe, it did not work for most patients because it failed to multiply the right immune cells. However, one exceptional response suggests that certain genetic profiles might still benefit from this approach in the future.